CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
CONMED (NYSE: CNMD) announced its leadership team's upcoming participation in a fireside chat at the Piper Sandler Healthcare Conference. President and CEO Curt R. Hartman, EVP and CFO Todd W. Garner, and COO Pat J. Beyer will represent the company at the event scheduled for December 3, 2024, at 12:30 p.m. ET. The session will be accessible via live video webcast through CONMED's website investor section and will remain available for replay after the event.
CONMED (NYSE: CNMD) ha annunciato la partecipazione del suo team di leadership a una chiacchierata informale durante la Piper Sandler Healthcare Conference. Il Presidente e Amministratore Delegato Curt R. Hartman, il VP Esecutivo e CFO Todd W. Garner e il COO Pat J. Beyer rappresenteranno l'azienda all'evento in programma per il 3 dicembre 2024, alle 12:30 p.m. ET. La sessione sarà accessibile tramite webcast video in diretta nella sezione investitori del sito web di CONMED e rimarrà disponibile per la riproduzione dopo l'evento.
CONMED (NYSE: CNMD) anunció la participación de su equipo de liderazgo en un chat informal en la Piper Sandler Healthcare Conference. El Presidente y CEO Curt R. Hartman, el EVP y CFO Todd W. Garner, y el COO Pat J. Beyer representarán a la empresa en el evento programado para el 3 de diciembre de 2024, a las 12:30 p.m. ET. La sesión estará disponible a través de una transmisión en vivo por video en la sección de inversores del sitio web de CONMED y permanecerá accesible para su reproducción después del evento.
CONMED (NYSE: CNMD)는 Piper Sandler Healthcare Conference에서의 파이어사이드 챗에 대한 리더십 팀의 참여를 발표했습니다. 회장 겸 CEO인 Curt R. Hartman, EVP 겸 CFO인 Todd W. Garner, COO인 Pat J. Beyer가 2024년 12월 3일 오후 12시 30분 ET에 예정된 행사에서 회사를 대표할 것입니다. 이 세션은 CONMED 웹사이트의 투자자 섹션을 통해 생중계로 접근할 수 있으며, 이벤트 후 재생을 위해 계속 제공될 것입니다.
CONMED (NYSE: CNMD) a annoncé la participation prochaine de son équipe de direction à une discussion informelle lors de la Piper Sandler Healthcare Conference. Le Président et CEO Curt R. Hartman, le EVP et CFO Todd W. Garner, ainsi que le COO Pat J. Beyer représenteront l'entreprise lors de cet événement prévu pour le 3 décembre 2024, à 12h30 ET. La session sera accessible via un webinaire vidéo en direct dans la section investisseurs du site web de CONMED et restera disponible en replay après l'événement.
CONMED (NYSE: CNMD) hat die bevorstehende Teilnahme seines Führungsteams an einem informellen Gespräch auf der Piper Sandler Healthcare Conference bekannt gegeben. Präsident und CEO Curt R. Hartman, EVP und CFO Todd W. Garner sowie COO Pat J. Beyer werden das Unternehmen bei der Veranstaltung vertreten, die für den 3. Dezember 2024, um 12:30 Uhr ET geplant ist. Die Sitzung wird über einen Live-Video-Stream im Investorenbereich der CONMED-Website zugänglich sein und bleibt nach der Veranstaltung für eine Wiederholung verfügbar.
- None.
- None.
A live video webcast of the fireside chat will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the event.
About CONMED Corporation
CONMED is a medical technology company that provides devices and equipment for surgical procedures. The Company’s products are used by surgeons and other healthcare professionals in a variety of specialties including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.
Forward-Looking Statements
This press release and associated webcast may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2023, listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q and other risks and uncertainties, which may be detailed from time to time in reports filed by CONMED with the SEC. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241118548114/en/
CONMED Corporation
Todd W. Garner
Chief Financial Officer
727-214-2975
ToddGarner@conmed.com
Source: CONMED Corporation
FAQ
When is CONMED (CNMD) presenting at the Piper Sandler Healthcare Conference 2024?
How can I watch CONMED's (CNMD) Piper Sandler Healthcare Conference presentation?